| |
|
|
|
Kazia Therapeutics Limited  
|
|
2.7206 0.033 (0.01%) |
12-11 15:04 |
|
Open: |
2.7258 |
Pre close: |
2.688 |
Target:
|
3.50
|
|
High: |
2.7258 |
Low: |
2.7206 |
Resistance:
|
3.00
3.50
|
|
Volume: |
533 |
Market Cap: |
17M |
Support:
|
2.41
2.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.71
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
2.68 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
3.11  |
Stochastic Oscillator |
%K(14,3):
|
63.18 |
|
MA(250): |
3.95 |
%D(3): |
66.54 |
|
Average Volume(K) |
3-Month: |
325
|
52-Week |
High:
|
6.68 |
|
10-Days: |
136 |
Low: |
2.04 |
|
RSI |
RSI(14):
|
49.82 |
Change(%): |
-0.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-26.5 |
Shares Out. (M) |
4.84 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-18.5 |
Shares Float (M) |
4.82 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-63.0 |
% Held by Institutions |
5.50 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.920 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.96 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.40 |
P/S |
286313568.00 |
|
Operating Margin |
-411.41 |
Levered Free Cash Flow
(M) |
-4.26 |
P/CF |
-2.06 |
|
|
|
|
|
|
